Special Introductory Offer: Try 7 Days for Free!

Start Today

Special Introductory Offer: Try 7 Days for Free!

Start Today

Healthcare Providers

Looking for BladderBoss brochures for your practice, or have a general enquiry for the BladderBoss team? Contact us today!

BladderBoss is a revolutionary 8-week digital-program, delivered via a mobile app, empowering women to take control of their bladder health at home. With over 17 million people in the United States alone suffering from Overactive Bladder, there is a growing demand for accessible and affordable bladder health management solutions. BladderBoss offers a convenient, supportive approach to better bladder health and quality of life.

Our team of experts in urogynecology, psychology, physical therapy and dietetics have created a user-friendly app with a holistic program, consisting of 8 interactive weekly modules and engaging challenges, with a built-in bladder diary for tracking bathroom behaviors. BladderBoss is filling a critical need in women's bladder health. Our mission is simple - empower women to take control of their Overactive Bladder. .

BladderBoss Icon
Thank You!

Your submission has been received and someone will be in touch shortly...!
Oops! Something went wrong while submitting the form.

Our Mission

Empower women with Overactive Bladder (OAB) to improve their bladder health so that they can live healthier and happier lives.

Our Aim

To investigate the feasibility acceptability and preliminary efficacy of a digital intervention, the OAB App, for the conservative management of overactive bladder.

Our Methods

Design
• Single arm, pre-test post-test trial
• Clinical Trial registration number: NCT05170100
Inclusion criteria
• On waiting list
• Referred for OAB from GP
• Symptoms of OAB to include at least one of the following: urgency of urination, frequency of urination or urge of incontinence.
• Female
• Own a smartphone
Exclusion criteria
• Active/Recurrent urinary tract infection
• Urinary retention
• Bladder Pain Syndrome/Interstitial cystitis
• Pelvic/gynae cancer
• Pregnant
• Dementia
• Kidney problems
• Stroke
• Have/had a neuro-stimulation implant for treatment of OAB

Recruitment
• Clinics contacted patients with brief study description and a recommendation to participate
• Patients completed online ‘consent to be contacted’ form
• Study team provided participant information leaflet
• Participants completed online informed consent form and downloaded the OAB app

Outcomes
• 72 hour digital bladder diary
• Incontinence Questionnaire Overactive Bladder (ICIQ-OAB)
• Incontinence Questionnaire Overactive Bladder: Quality of Life (ICIQ-OABQoL)

Our Conclusion

The OAB app improved patients’ quality of life by reducing the symptoms of urgency, frequency, nocturia and incontinence.

Patients using the OAB app experienced:
• significant reduction in OAB symptoms  
• significant improvement in quality of life  
• significant decrease in frequency of urination
• reduction in average number of incontinence episodes

The OAB app provides potential for the conservative management of patients with OAB.

The OAB App pilot study: Evaluating a digital intervention for overactive bladder

Sooknarine C, Salameh F, Burke N, Staunton B, Carr E, Sexton K, Agnew G, Downey A, D’Arcy F, Sarma S, Cundiff G

Graph 1Graph 2

100% of participants (n=18) reported a reduction in theirOAB symptoms

Paired samples t tests
Significant difference in ICIQ-OAB scoresa:
• Between baseline (M = 7.13, SD = 2.53) and week 4 (M = 5.19, SD = 2.46; t(15) = 3.78, p =.002).
• Between baseline and week 8 (M = 5.00, SD = 2.52; t(16) = 5.28, p < .001).

83% of participants (n=18) reported an improvement in their Quality of Life

Paired samples t tests
Significant difference in ICIQ-OAB-QoL scoresa:
• Between baseline (M = 84.45, SD =20.50) and week 4 (M = 69.06, SD = 22.14; t(15) = 3.12, p = .007).
• Between baseline and week 8 (M = 62.41, SD = 31.28; t(16) = 3.52, p = .003).

Bladder Diary Results: Frequency reduced to within normal range

Significant difference in Frequency of Urination between baseline (M = 10.19, SD 3.41) and week 8 (M = 6.71, SD = 1.25; t(6) = 3.28, p = .017).

Bladder Diary Results: Incontinence episodes

Incontinence Episodes at Baseline: M = 10.00, SD = 15.17Incontinence Episodes at Week 8: M = 3.57, SD = 4.58

Download PDF
QR Code

Take a smartphone photo of this QR code to view the complete protocol or visit:
www.clinicaltrials.gov/ct2/show/NCT05170100

The following centers took part in our pilot study:

RCSI LogoRotunda Hospital LogoUniversity of Galway LogoThe National Maternity HospitalGUH Logo

So Why Wait?

Download BladderBoss now and start your journey towards better bladder health.

Instagram IconYouTube IconLinkedin Icon